Article
Radiology, Nuclear Medicine & Medical Imaging
Taeho Ha, Wooil Kim, Jaehyung Cha, Young Hen Lee, Hyung Suk Seo, So Young Park, Nan Hee Kim, Sung Ho Hwang, Hwan Seok Yong, Yu-Whan Oh, Eun-Young Kang, Cherry Kim
Summary: DECT parameters play an important role in distinguishing between metastatic and benign lung nodules in thyroid cancer. The study found that specific cutoff values for IC, NIC, lambda HU, NICPA, and Z(eff) can aid in diagnosing metastases.
EUROPEAN RADIOLOGY
(2022)
Review
Oncology
Tiuri E. Kroese, Hanneke W. M. Van Laarhoven, Magnus Nilsson, Florian Lordick, Matthias Guckenberger, Jelle P. Ruurda, Domenico D'Ugo, Karin Haustermans, Eric Van Cutsem, Richard Van Hillegersberg, Peter S. N. Van Rossum
Summary: Local treatment may improve overall survival in patients with esophagogastric cancer and oligometastatic disease (OMD). The current literature defines OMD as the presence of metastases limited to one organ with no more than three lesions and the presence of an extra-regional lymph node station. Local treatment appears to be associated with improved OS compared to systemic therapy alone.
EUROPEAN JOURNAL OF CANCER
(2022)
Article
Immunology
Vincent D. Giacalone, Diego Moncada Giraldo, George L. Silva, Justin Hosten, Limin Peng, Lokesh Guglani, Rabindra Tirouvanziam
Summary: This study found that early-life pulmonary exacerbations (PEs) activate airway T cells and shift CF airway immunity towards neutrophil dominance.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Oncology
Shaoyan Lin, Hongnan Mo, Yiqun Li, Xiuwen Guan, Yimeng Chen, Zijing Wang, Binghe Xu
Summary: The study revealed significant associations between incidence of lung metastases and factors such as age, ECOG grade, tumor subtype in the Chinese Han population; BCLM patients had a median survival of 41.7 months, with the worst prognosis seen in triple-negative subtype patients.
Article
Oncology
Kelsey L. Corrigan, Alison Yoder, Brian De, Lilie Lin, Anuja Jhingran, Melissa M. Joyner, Patricia J. Eifel, Lauren E. Colbert, Karen H. Lu, Ann H. Klopp
Summary: This study aimed to evaluate the long-term survival of patients with recurrent or oligometastatic gynecological cancer (ROMGC) treated with radiation therapy (RT) and investigate their clinical characteristics. The study found that patients in the chemoradiation group had higher median disease-free survival (DFS) compared to those treated with RT alone. Further randomized studies are needed to identify the patients who would benefit the most.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Oncology
Tiuri E. Kroese, Sebastian M. Christ, Peter S. N. van Rossum, Matthijs D. L. Burger, George S. Buijs, Urs Muhlematter, Nicolaus Andratschke, Jelle P. Ruurda, Martin Hullner, Christian A. Gutschow, Richard van Hillegersberg, Matthias Guckenberger
Summary: This multicenter study assessed the incidence and survival of patients with esophagogastric cancer and oligometastatic disease (OMD) in two tertiary referral cancer centers in The Netherlands and Switzerland. The study found that local treatment plus systemic therapy was associated with improved overall survival compared to systemic therapy alone.
RADIOTHERAPY AND ONCOLOGY
(2022)
Article
Oncology
Ana Luzarraga Aznar, Vicente Bebia, Carlos Lopez-Gil, Alexandra Giraldo, M. P. Montoya, Ramona Verges, Alberto Jauregui, Josep Castellvi, Assumpcio Perez-Benavente, Eva Colas, Antonio Gil-Moreno, Silvia Cabrera
Summary: The objective of this study was to describe the characteristics of patients with endometrial cancer diagnosed with a first recurrence involving the lung, and to explore the prognostic role of the molecular profile. The study also aimed to describe the prognostic outcomes after local treatment of isolated lung recurrence.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2023)
Article
Oncology
Lucas W. Thornblade, Ernest Han, Yuman Fong
Summary: Patients with colorectal cancer ovarian metastasis have favorable long-term survival. Survival rates are higher if the tumor is isolated to the ovary or if metachronous to the primary cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2021)
Article
Urology & Nephrology
Jack R. Andrews, Mohamed E. Ahmed, Vidit Sharma, Cameron Britton, Bradley Stish, Ryan Phillips, A. Tuba Kendi, Vidhu B. Joshi, Akshay Sood, Mathew K. Tollefson, Stephen A. Boorjian, R. Jeffery Karnes, Eugene D. Kwon
Summary: This study characterizes the outcomes of metastasis-directed therapy without concurrent androgen deprivation therapy in patients with solitary metastatic lesions in prostate cancer. The results demonstrate that this approach can delay the initiation of systemic therapy and call for further prospective studies in patients with solitary recurrent prostate cancer metastases.
JOURNAL OF UROLOGY
(2022)
Article
Urology & Nephrology
Nicholas H. Chakiryan, Aaron Dahmen, Marco Bandini, Filippo Pederzoli, Laura Marandino, Maarten Albersen, Eduard Roussel, Yao Zhu, Ding-Wei Ye, Antonio A. Ornellas, Mario Catanzaro, Oliver W. Hakenberg, Axel Heidenreich, Friederike Haidl, Nick Watkin, Michael Ager, Jad Chahoud, Alberto Briganti, Roberto Salvioni, Francesco Montorsi, Andrea Necchi, Philippe E. Spiess
Summary: This study found that 31.9% of pSCC patients experienced post-ILND recurrence, which was associated with high pN staging. Over 95% of distant, inguinal, and pelvic recurrences occurred within 48 months post-ILND. Local recurrences occurred over a longer timeline, highlighting the necessity of long-term surveillance of the primary site.
JOURNAL OF UROLOGY
(2021)
Article
Pathology
Isaac K. S. Ng, Nesaretnam Barr Kumarakulasinghe, Nicholas L. Syn, Ross Andrew Soo
Summary: In this study, serum LDH and lung/pleural metastasis were identified as independent predictors of unfavorable overall survival in patients with advanced, EGFR mutation-positive NSCLC. A nomogram-based risk score incorporating multiple variables was developed to provide more targeted prognostication and management for this patient subgroup.
JOURNAL OF CLINICAL PATHOLOGY
(2021)
Review
Surgery
Hoon Choi, Wonjung Hwang
Summary: Surgical resection is the main treatment for solid tumors, but cancer recurrence after surgery is common. Maintaining anti-tumor cell activity and proper levels of inflammatory mediators are crucial for preventing recurrence. Surgery itself and perioperative interventions can affect these physiological responses.
FRONTIERS IN SURGERY
(2022)
Article
Pathology
Julien Dagher, Angelique Brunot, Bertrand Evrard, Solene-Florence Kammerer-Jacquet, Marion Beaumont, Laurence Cornevin, Fanny Derquin, Gregory Verhoest, Karim Bensalah, Alexandra Lespagnol, Frederic Dugay, Marc-Antoine Belaud-Rotureau, Frederic Chalmel, Nathalie Rioux-Leclercq
Summary: Metastatic evolution in clear cell renal cell carcinoma is complex, with tumor heterogeneity resulting from clonal evolution playing a role in metastatic dissemination. Using an integrative multiomics strategy, it was found that all sites were heterogeneous and polyclonal, with each tumor site containing two aggressive subclonal populations.
JOURNAL OF CLINICAL PATHOLOGY
(2022)
Article
Urology & Nephrology
Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frederic Pouliot, Stephan Probst, Lawrence Saperstein, Mark A. Preston, Ajjai S. Alva, Akash Patnaik, Jeremy C. Durack, Nancy Stambler, Tess Lin, Jessica Jensen, Vivien Wong, Barry A. Siegel, Michael J. Morris
Summary: The study aimed to evaluate the diagnostic performance of F-18-DCFPyL positron emission tomography/computerized tomography in detecting metastatic sites of prostate cancer. The results showed high specificity and positive predictive value, but moderate sensitivity.
JOURNAL OF UROLOGY
(2021)
Article
Microbiology
Andrew Oliver, Kenza El Alaoui, Carolyn Haunschild, Julio Avelar-Barragan, Laura F. Mendez Luque, Katrine Whiteson, Angela G. Fleischman
Summary: This study found significant differences in the gut microbiome between MPN patients and non-MPN controls, suggesting that specific microbial species may play a role in the chronic inflammation associated with MPNs.
MICROBIOLOGY SPECTRUM
(2022)
Article
Biochemistry & Molecular Biology
Mariya Farooqui, Laura R. Bohrer, Nicholas J. Brady, Pavlina Chuntova, Sarah E. Kemp, C. Taylor Wardwell, Andrew C. Nelson, Kathryn L. Schwertfeger
Article
Endocrinology & Metabolism
Mihir Gupta, Tasneem Poonawala, Mariya Farooqui, Marna E. Ericson, Kalpna Gupta
JOURNAL OF DIABETES
(2015)
Article
Medical Laboratory Technology
Ping Wang, Mihir Gupta, Tasneem Poonawala, Mariya Farooqui, Yunfang Li, Fei Peng, Sheldon Rao, Michael Ansonoff, John E. Pintar, Kalpna Gupta
TRANSLATIONAL RESEARCH
(2017)
Article
Oncology
Jill M. Siegfried, Mariya Farooqui, Natalie J. Rothenberger, Sanja Dacic, Laura P. Stabile
Article
Oncology
Laura P. Stabile, Mariya Farooqui, Beatriz Kanterewicz, Shira Abberbock, Brenda F. Kurland, Brenda Diergaarde, Jill M. Siegfried
JOURNAL OF THORACIC ONCOLOGY
(2018)
Article
Oncology
Christian Njatcha, Mariya Farooqui, Adam Kornberg, Daniel E. Johnson, Jennifer R. Grandis, Jill M. Siegfried
MOLECULAR CANCER THERAPEUTICS
(2018)
Article
Anesthesiology
M. L. Weber, C. Chen, Y. Li, M. Farooqui, J. Nguyen, T. Poonawala, R. P. Hebbel, K. Gupta
BRITISH JOURNAL OF ANAESTHESIA
(2013)
Article
Multidisciplinary Sciences
Catherine A. St Hill, Dahabo Baharo-Hassan, Mariya Farooqui
Review
Oncology
Oshin Miranda, Mariya Farooqui, Jill M. Siegfried
Article
Oncology
Abdulaziz A. Almotlak, Mariya Farooqui, Jill M. Siegfried
JOURNAL OF THORACIC ONCOLOGY
(2020)
Article
Oncology
Christian Njatcha, Mariya Farooqui, Abdulaziz A. Almotlak, Jill M. Siegfried
CANCER PREVENTION RESEARCH
(2020)
Article
Pathology
Mahmoud A. Khalifa, Brooke Gagner, Liam Chen, Paari Murugan, Molly E. Klein, Emilian Racila, Khalid Amin, Daniel Miller, Jimmie Stewart III, Yanli Ding, Mariya Farooqui, Sandhyarani Dasaraju, Oyedele A. Adeyi
Summary: The study investigated the utilization of immunohistochemistry (IHC) and immunofluorescence (IF) in the daily practice of pathologists and introduced a methodology for auditing their usage. The results showed variations in the utilization patterns across different subspecialties, with renal pathology exhibiting significant differences compared to others. Additionally, the study analyzed cases that exceeded reimbursement limits.
ANNALS OF DIAGNOSTIC PATHOLOGY
(2023)
Article
Oncology
Jaswinder Chalia, Musse Hussein, Mariya Farooqui, Jordan Mattson, Sally A. Mullany, Molly E. Klein, Boris Winterhoff, Mahmoud A. Khalifa
Summary: The study investigated the impact of concurrent LiCAM testing with MMR testing on endometrial cancer. It was found that L1CAM positivity is not mutually exclusive with MMR status. Performing L1CAM immunostaining may aid in appropriate treatment for patients with L1CAM positivity, particularly in cases classified as MMR-proficient within the NSMP category.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
(2021)
Article
Oncology
Ahmad A. Tarhini, Imran Rafique, Theofanis Floros, Phu Tran, William E. Gooding, Liza C. Villaruz, Timothy F. Burns, David M. Friedland, Daniel P. Petro, Mariya Farooqui, Jose Gomez-Garcia, Autumn Gaither-Davis, Sanja Dacic, Athanassios Argiris, Mark A. Socinski, Laura P. Stabile, Jill M. Siegfried